Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Background There is conclusive evidence from clinical trials that reduction of mortality by fibrinolytic therapy in acute myocardial infarction is related to the time elapsing between onset of symptoms and commencement of treatment. However, the exact pattern of this relation continues to be debated. This paper discusses whether or not appreciable additional gain can be achieved with very early treatment.Methods The relation between treatment delay and short-term mortality (up to 35 days) was evaluated using tabulated data from all randomised trials of at least 100 patients (n = 22; 50,246 patients) that compared fibrinolytic therapy with placebo or control, reported between 1983 and 1993.Findings Benefit of fibrinolytic therapy was 65 (SD 14), 37 (9), 26 (6) and 29 (5) lives saved per 1000 treated patients in the 0-1, 1-2, 2-3, and 3-6 h intervals, respectively. Proportional mortality reduction was significantly higher in patients treated within 2 h compared to those treated later (44% [95% CI 32, 53] vs 20% [15, 25]; p = 0.001). The relation between treatment delay and mortality reduction per 1000 treated patients was expressed significantly better by a non-linear (19.4-0.6x(+)29.3x-1) than a linear (34.7 - 1.6x) regression equation (p = 0.03).Interpretation The beneficial effect of fibrinolytic therapy is substantially higher in patients presenting within 2 h after symptom onset compared to those presenting later.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which have proven so useful in the treatment of asthma, myocardial infarction, and stroke.93, 94, 95”
Citations
Cites
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
GRUPPOITALIANOPERLOSTUDIODELL (1986) · The Lancet · doi:10.1016/s0140-6736(86)92368-8 · Cited by 2,440
Reimer, K. A., Lowe, J. E., Rasmussen, M. M., & Jennings, R. B. (1977) · Circulation · doi:10.1161/01.cir.56.5.786 · Cited by 1,944
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
Wilcox, R. G., Olsson, C. G., Skene, A. M., Von Der Lippe, G., Jensen, G., Hampton, J. R., & For The Asset Study Group (1988) · The Lancet · doi:10.1016/s0140-6736(88)92656-6 · Cited by 1,153
Hunt, D. U., Varigos, G., Dienstl, F., Lechleitner, P., DeBacker, G., Kornitzer, M., Cairns, J., Turpie, A. G. G., Fritz-Hansen, P., Skagen, K., et al. (1992) · The Lancet · Cited by 894
Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
Kennedy, J. W., Ritchie, J. L., Davis, K. B., & Fritz, J. K. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312153092402 · Cited by 788
A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
The I.S.A.M. Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198606053142301 · Cited by 726
Weaver, W. D. (1993) · JAMA · doi:10.1001/jama.270.10.1211 · Cited by 685
White, H. D., Norris, R. M., Brown, M. A., Takayama, M., Maslowski, A., Bass, N. M., Ormiston, J. A., & Whitlock, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710013171402 · Cited by 621
McManus, J. L. (1994) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(94)70199-7 · Cited by 483
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
Simoons, M. L., Brand, M. V., Zwaan, C. D., Verheugt, F. W. A., Remme, W. J., Serruys, P. W., Bär, F., Res, J., Krauss, X. H., Vermeer, F., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90584-7 · Cited by 451
Self-citationPrehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial Infarction
(1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290602 · Cited by 418
Van de Werf, F., & Arnold, A. E. (1988) · BMJ · doi:10.1136/bmj.297.6660.1374 · Cited by 381
Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
Honan, M. B., Harrell, F. E., Reimer, K. A., Califf, R. M., Mark, D. B., Pryor, D. B., & Hlatky, M. A. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90586-e · Cited by 278
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
Kennedy, J. W., Martin, G. V., Davis, K. B., Maynard, C., Stadius, M., Sheehan, F. H., & Ritchie, J. L. (1988) · Circulation · doi:10.1161/01.cir.77.2.345 · Cited by 244
Verstraete, M., Brower, R. W., Collen, D., Dunning, A. J., Lubsen, J., Michel, P. L., Schofer, J., Vanhaecke, J., Van De Werf, F., Bleifeld, W., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90523-9 · Cited by 238
O'Rourke, M., Baron, D., Keogh, A., Kelly, R., Nelson, G., Barnes, C., Raftos, J., Graham, K., Hillman, K., & Newman, H. (1988) · Circulation · doi:10.1161/01.cir.77.6.1311 · Cited by 228
Basu, S., Senior, R., Raftery, E. B., & Lahiri, A. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_f.43 · Cited by 188
Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction
(1993) · The Lancet · doi:10.1016/0140-6736(93)91539-x · Cited by 181
Rentrop, K. P., Feit, F., Sherman, W., & Thornton, J. C. (1989) · Circulation · doi:10.1161/01.cir.80.5.1166 · Cited by 159
Reimer, K. A., Heide, R. S. V., & Richard, V. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90102-i · Cited by 152
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
Vermeer, F., Simoons, M. L., Bär, F. W. H. M., Tijssen, J. G. P., van Domburg, R. T., Serruys, P. W. J. C., Verheugt, F. W. A., Res, J., de Zwaan, C., & van der Laarse, A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1379 · Cited by 143
Self-citationTime to thrombolytic treatment: Factors affecting delay and their influence on outcome
Weaver, W. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00108-g · Cited by 143
Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion
GARCIA-DORADO, D., Théroux, P., Elízaga, J., Galiñanes, M., Solares, J., Riesgo, M. J., GOMEZ, M. J., GARCIA-DORADO, A., & AVILES, F. F. (1987) · Cardiovascular Research · doi:10.1093/cvr/21.7.537 · Cited by 126
Bett, J. H. N. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb04754.x · Cited by 126
Yarzebski, J., Goldberg, R. J., Gore, J. M., & Alpert, J. S. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90477-4 · Cited by 124
Prehospital use of APSAC: Results of a placebo-controlled study
Castaigne, A., Hervé, C., Duval-Moulin, A.-M., Gaillard, M., Dubois‐Randé, J., Boesch, C., Wolf, M., LELLOUCHE, D., Jan, F., Vernant, P., et al. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90927-2 · Cited by 124
Turi, Z. G., Stone, P. H., Muller, J. E., Parker, C. B., Rude, R. E., Raabe, D. E., Jaffe, A. S., Hartwell, T., Robertson, T. L., & D, E. B. M. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90047-0 · Cited by 123
Prehospital thrombolysis in acute myocardial infarction
Schofer, J. J., Büttner, J., Geng, G., Gutschmidt, K., Herden, H. N., Mathey, D. G., Moecke, H. P., Polster, P., Raftopoulo, A., Sheehan, F. H., et al. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90528-9 · Cited by 123
Armstrong, P. W., Baigrie, R. S., Daly, P. A., Haq, A., Gent, M., Roberts, R. S., Freeman, M. R., Burns, R. A., Liu, P. J., & Morgan, C. D. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90334-3 · Cited by 115
Davies, G. J., Chierchia, S. L., & Maseri, A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412063112306 · Cited by 113
Schaper, W. K. A., BINZ, K., Sass, S., & Winkler, B. E. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80542-4 · Cited by 105
Bär, F. W. H. M., Verheugt, F. W. A., Col, J. J., Materne, P., Monassier, J. P., Geslin, P., Metzger, J., Raynaud, P., Foucault, J. P., & de Zwaan, C. (1992) · Circulation · doi:10.1161/01.cir.86.1.131 · Cited by 90
Tailored thrombolytic therapy. A perspective.
Simoons, M. L., & Arnold, A. E. R. (1993) · Circulation · doi:10.1161/01.cir.88.6.2556 · Cited by 90
Self-citationVery early thrombolytic therapy in suspected acute myocardial infarction
Herlitz, J. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90800-g · Cited by 81
Barbash, G. I., Roth, A., Hod, H., Miller, H. I., Modan, M., Rath, S., Zahav, Y. H., Shachar, A., Basan, S., Battler, A., et al. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90832-l · Cited by 70
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction
BOUTEN, M. J. M., Simoons, M. L., Hartman, J. A. M., van Miltenburg, A. J. M., van der Does, E., & Pool, J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060294 · Cited by 69
Self-citationComparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
Paolo, R., & Bolognese, L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90348-o · Cited by 62
Effect of thrombolytic treatment delay on myocardial infarct size
Hermens, W. T., Willems, G. M., Nijssen, K. M., Simoons, M. L., & European Cooperative Study Group (1992) · The Lancet · doi:10.1016/0140-6736(92)93003-6 · Cited by 54
Self-citationIkram, S., Lewis, S., Bucknall, C. A., Sram, I., Thomas, N. J., Vincent, R., & Chamberlain, D. A. (1986) · BMJ · doi:10.1136/bmj.293.6550.786 · Cited by 53
Determinants of infarct size in non-human primates
Flameng, W., Lesaffre, E. M. E. H., & Vanhaecke, J. (1990) · Basic Research in Cardiology · doi:10.1007/bf01907131 · Cited by 48
MCNEILL, A. J., Cunningham, S. R., Flannery, D. J., Dalzell, G. W. N., Wilson, C. M., Campbell, N. P. S., Khan, M. M., Patterson, G. C., Webb, S. W., & Adgey, A. A. J. (1989) · Heart · doi:10.1136/hrt.61.4.316 · Cited by 45
Prehospital thrombolysis in a rural community: Short- and long-term survival
McAleer, B., Ruane, B., Burke, E., Cathcart, M., Costello, A., Dalton, G., Williams, J. R., & Varma, M. P. S. (1992) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00054183 · Cited by 33
Spears, B. (1990) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81579-3 · Cited by 19
Thrombolytic Therapy Within One Hour of the Onset of Acute Myocardial Infarction
MCNEILL, A. J., Flannery, D. J., WILSON, C., Dalzell, G. W. N., Campbell, N., KHAN, M., Patterson, G. C., Sw, W., & Adgey, A. A. J. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068569 · Cited by 11
Thrombolysis in refractory unstable angina
Brunelli, C., Spallarossa, P., Ghigliotti, G., Iannetti, M., & Caponnetto, S. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90393-y · Cited by 10
Fibrinolytic therapy in suspected acute myocardial infarction
Fath‐Ordoubadi, F., Kj, B., Davis, R. C., CARLSSON, J., Rahlf, G., & Tebbe, U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90029-9 · Cited by 4
Brunelli, C., Spallarossa, P., Ghigliotti, G., Iannetti, M., Mt, F., Tondi, S., Traina, M., Hoffmann, E., Gl, M., & Biase, L. D. (1988) · PubMed · Cited by 3
Research works printed but not linked: 3
- Fath-Ordoubadi, 1994, Meta-analysis of randomised trials of prehospital versus hospital thrombolysis, Circulation, 90, I-325
- 1988, Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial, Lancet, i, 545
- 1988, Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to 4 h after onset of myocardial infarction, Lancet, i, 203
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
“In the clinical context, a “golden hour” has been described for therapy of hypovolemic shock due to trauma (27), cardiogenic shock due to myocardial infarction (28), and, most recently, obstructive shock due to massive pulmonary embolus (29).”
Background
Metadata
- Authors
- Boersma, E., Maas, A. C., Deckers, J. W., & Simoons, M. L.
- Affiliations
- Erasmus University Rotterdam (NL)
- Corresponding author
- Simoons, Maarten L
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1996-09
- Volume
- 348
- Issue
- 9030
- Pages
- 771-775
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2129805832
- Cited by
- 1,299
- References
- 55
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 18 · 2023: 28 · 2022: 28 · 2021: 29 · 2020: 29 · 2019: 42 · 2018: 34 · 2017: 35 · 2016: 44 · 2015: 37 · 2014: 53 · 2013: 50 · 2012: 54
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- acute myocardial infarction, thrombolysis, golden hour, treatment delay, time to treatment, short-term mortality, mortality reduction, nonlinear dose-response relationship, randomised trials
- MeSH terms
- Animals, Fibrinolytic Agents, Humans, Myocardial Infarction, Time Factors, Thrombolytic Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.